Wednesday, May 11, 2022 NIAID Scientists Advance Understanding of Broadly Protective Flu Vaccines NIAID Vaccine Research Center scientists designed a ferritin nanoparticle flu vaccine and tested it in people with and without experience of the 1957 pandemic flu virus. The vaccine was safe and prompted immune responses in both older and younger trial participants. Ferritin nanoparticle vaccines like this one could one day provide long-lasting protection against many flu virus subtypes. Read about the research on the NIAID Now blog. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, May 11, 2022 — Add Comment